Next Article in Journal
Potentiality and Boundaries of Use of Sorafenib in Patients with Hepatocellular Carcinoma: Awaiting the Results of Ongoing Clinical Trials
Next Article in Special Issue
Macrophage-Mediated Lymphangiogenesis: The Emerging Role of Macrophages as Lymphatic Endothelial Progenitors
Previous Article in Journal
Epidermal to Mesenchymal Transition and Failure of EGFR-Targeted Therapy in Glioblastoma
Previous Article in Special Issue
T-Cell Mediated Immune Responses Induced in ret Transgenic Mouse Model of Malignant Melanoma

The Stroma—A Key Regulator in Prostate Function and Malignancy

Department of Medical Biosciences, Pathology, Umeå University, Umeå 90185, Sweden
Author to whom correspondence should be addressed.
Cancers 2012, 4(2), 531-548;
Received: 9 April 2012 / Revised: 20 May 2012 / Accepted: 21 May 2012 / Published: 29 May 2012
(This article belongs to the Special Issue Tumor Stroma)
Prostate cancer is a very common and highly unpredictable form of cancer. Whereas many prostate cancers are slow growing and could be left without treatment, others are very aggressive. Additionally, today there is no curative treatment for prostate cancer patients with local or distant metastasis. Identification of new, improved prognostic and diagnostic biomarkers for prostate cancer and the finding of better treatment strategies for metastatic prostate cancer is therefore highly warranted. Interactions between epithelium and stroma are known to be important already during prostate development and this interplay is critical also in development, progression of primary tumors and growth of metastases. It is therefore reasonable to expect that future biomarkers and therapeutic targets can be identified in the prostate tumor and metastasis stroma and this possibility should be further explored. View Full-Text
Keywords: prostate; cancer; metastasis; microenvironment; stroma prostate; cancer; metastasis; microenvironment; stroma
MDPI and ACS Style

Hägglöf, C.; Bergh, A. The Stroma—A Key Regulator in Prostate Function and Malignancy. Cancers 2012, 4, 531-548.

AMA Style

Hägglöf C, Bergh A. The Stroma—A Key Regulator in Prostate Function and Malignancy. Cancers. 2012; 4(2):531-548.

Chicago/Turabian Style

Hägglöf, Christina, and Anders Bergh. 2012. "The Stroma—A Key Regulator in Prostate Function and Malignancy" Cancers 4, no. 2: 531-548.

Find Other Styles

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Back to TopTop